Author Correction: Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance (Nature Cancer, (2022), 3, 9, (1071-1087), 10.1038/s43018-022-00431-9)

Su Deng, Choushi Wang, Yunguan Wang, Yaru Xu, Xiaoling Li, Nickolas A. Johnson, Atreyi Mukherji, U. Ging Lo, Lingfan Xu, Julisa Gonzalez, Lauren A. Metang, Jianfeng Ye, Carla Rodriguez Tirado, Kathia Rodarte, Yinglu Zhou, Zhiqun Xie, Carlos Arana, Valli Annamalai, Xihui Liu, Donald J. Vander GriendDouglas Strand, Jer Tsong Hsieh, Bo Li, Ganesh Raj, Tao Wang, Ping Mu

Research output: Contribution to journalComment/debatepeer-review

2 Scopus citations

Abstract

In the version of this article initially published, the affiliation listed for Jer-Tsong Hsieh was incorrect. The correct affiliation (Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA) has now been inserted in the HTML and PDF versions of the article.

Original languageEnglish (US)
Pages (from-to)1271
Number of pages1
JournalNature Cancer
Volume3
Issue number10
DOIs
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Author Correction: Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance (Nature Cancer, (2022), 3, 9, (1071-1087), 10.1038/s43018-022-00431-9)'. Together they form a unique fingerprint.

Cite this